Jeffrey H. Murray

Array ( [id] => 6189968 [patent_doc_number] => 20110172252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'TRIAZOLO[4,5-D]PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/997721 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27564 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172252.pdf [firstpage_image] =>[orig_patent_app_number] => 12997721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545423 [patent_doc_number] => 20100016303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/487694 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24740 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016303.pdf [firstpage_image] =>[orig_patent_app_number] => 12487694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232855 [patent_doc_number] => 08198287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Substituted heteroaryl pyridopyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 12/487270 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25077 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198287.pdf [firstpage_image] =>[orig_patent_app_number] => 12487270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374987 [patent_doc_number] => 20090312548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'MODIFIED PICTET-SPENGLER REACTION AND PRODUCTS PREPARED THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/486817 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4124 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312548.pdf [firstpage_image] =>[orig_patent_app_number] => 12486817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608286 [patent_doc_number] => 08785452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Anti-infective compounds' [patent_app_type] => utility [patent_app_number] => 12/999095 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 49 [patent_no_of_words] => 59985 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580006 [patent_doc_number] => 20110293889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'NOVEL AND IMPROVED PROCESSES FOR THE PREPARATION OF PALIPERIDONE' [patent_app_type] => utility [patent_app_number] => 12/997982 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7978 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293889.pdf [firstpage_image] =>[orig_patent_app_number] => 12997982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494039 [patent_doc_number] => 20100093721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/479247 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14409 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093721.pdf [firstpage_image] =>[orig_patent_app_number] => 12479247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127978 [patent_doc_number] => 20110086865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/995361 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3644 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086865.pdf [firstpage_image] =>[orig_patent_app_number] => 12995361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533561 [patent_doc_number] => 08309717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Process to prepare paliperidone and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 12/994693 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3965 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114853 [patent_doc_number] => 08158636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Compounds and methods for kinase modulation, and indications therefor' [patent_app_type] => utility [patent_app_number] => 12/467194 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63102 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158636.pdf [firstpage_image] =>[orig_patent_app_number] => 12467194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103991 [patent_doc_number] => 08153641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Compounds and methods for kinase modulation, and indications therefor' [patent_app_type] => utility [patent_app_number] => 12/467208 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50699 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153641.pdf [firstpage_image] =>[orig_patent_app_number] => 12467208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113136 [patent_doc_number] => 20110190241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'TARGETING AN HIV-1 NEF-HOST CELL KINASE COMPLEX' [patent_app_type] => utility [patent_app_number] => 12/988501 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15400 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190241.pdf [firstpage_image] =>[orig_patent_app_number] => 12988501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202928 [patent_doc_number] => 20110065714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'SUBSTITUTED QUINAZOLINES' [patent_app_type] => utility [patent_app_number] => 12/993033 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8750 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065714.pdf [firstpage_image] =>[orig_patent_app_number] => 12993033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002976 [patent_doc_number] => 20110118233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Certain Substituted Amides, Method of Making, and Method of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/991232 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25787 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118233.pdf [firstpage_image] =>[orig_patent_app_number] => 12991232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378275 [patent_doc_number] => 20100081670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/435864 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32299 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081670.pdf [firstpage_image] =>[orig_patent_app_number] => 12435864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797134 [patent_doc_number] => 08436003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines' [patent_app_type] => utility [patent_app_number] => 12/992715 [patent_app_country] => US [patent_app_date] => 2009-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552826 [patent_doc_number] => 20090286812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'GPR119 Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 12/433921 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286812.pdf [firstpage_image] =>[orig_patent_app_number] => 12433921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113492 [patent_doc_number] => 20110190306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Inhibitors of PLK' [patent_app_type] => utility [patent_app_number] => 12/989178 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10667 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190306.pdf [firstpage_image] =>[orig_patent_app_number] => 12989178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8017383 [patent_doc_number] => 08138194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Fused bicyclic pyrimidine compounds as aurora kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/428044 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18839 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138194.pdf [firstpage_image] =>[orig_patent_app_number] => 12428044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149937 [patent_doc_number] => 20110021532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE' [patent_app_type] => utility [patent_app_number] => 12/934100 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17763 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021532.pdf [firstpage_image] =>[orig_patent_app_number] => 12934100 [rel_patent_id] =>[rel_patent_doc_number] =>)